Page last updated: 2024-10-27

gliclazide and Dermatitis Exfoliativa

gliclazide has been researched along with Dermatitis Exfoliativa in 1 studies

Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.

Research Excerpts

ExcerptRelevanceReference
"Erythroderma is generalized exfoliative dermatitis, which involves more than 90% of the patient's skin."1.40Erythroderma secondary to gliclazide: a case report. ( Kacar, SD; Karaca, S; Ozuguz, P; Ozuguz, U; Tokyol, C, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ozuguz, P1
Kacar, SD1
Ozuguz, U1
Karaca, S1
Tokyol, C1

Other Studies

1 other study available for gliclazide and Dermatitis Exfoliativa

ArticleYear
Erythroderma secondary to gliclazide: a case report.
    Cutaneous and ocular toxicology, 2014, Volume: 33, Issue:4

    Topics: Aged; Dermatitis, Exfoliative; Drug Eruptions; Female; Gliclazide; Humans; Hyperglycemia; Hypoglycem

2014